by rss feed | Jul 28, 2022 | advanced cell technology, Astellas, biotechs, News Feeds, Ocata, Robert Lanza
The recent news of Vertex Pharma buying small stem cell biotech ViaCyte and Doug Melton moving to Vertex brought to mind an old stem cell biotech called Advanced Cell Technology (ACT) and its leader, stem cell biologist Dr. Robert Lanza. Years ago, big pharma firm...
